October 1, 2009 - While we wait for the definition of "meaningful use," Dr. David Blumenthal, M.D., M.P.P., National Coordinator for Health Information Technology, recommends physicians become "as familiar as possible with the discussion of meaningful use criteria to date."

October 1, 2009 – Flexible Stenting Solutions Inc. (FSS) said this week it received conditional investigational device exemption (IDE) approval from the FDA for its FlexStent Femoropopliteal Self-Expanding Stent System so it can begin its U.S. clinical trial at up to 10 clinical sites and with 50 patients.

October 1, 2009 – Transcatheter heart valve company CardiAQ Valve Technologies (CVT), which is developing the world’s first self-conforming and self-anchoring technology for transcatheter mitral valve implantation (TMVI) system, announced successful results at TCT 2009 from its acute in vivo study.

October 1, 2009 – The six-month clinical outcome of Sahajanand Medical Technologies Supralimus Sirolimus-Eluting Stent with a bioabsorbable polymer was highlighted by the company at TCT 2009.

October 1, 2009 – Invatec recently launched the REEF HP PTA Balloon Catheter at CIRSE 2009, which the company said is ideal for use in all peripheral high-pressure dilatation procedures.

October 1, 2009 – Spectranetics Corp. yesterday said it filed a 510(k) application with the U.S. Food and Drug Administration seeking clearance for the treatment of in-stent restenosis (ISR) in the legs with its commercially available peripheral atherectomy laser products.

September 30, 2009 – PLC Systems Inc. demonstrated its RenalGuard System to help prevent contrast-induced nephropathy (CIN) and presented data from its MYTHOS Clinical Trial at the Transcatheter Cardiovascular Therapeutics (TCT) 2009 symposium last week in San Francisco.

September 30, 2009 – Invatec this week at the European CIRSE 2009 conference launched its latest self-expanding peripheral stent system, Maris Plus, which has a “lesion-specific” design with larger sizes to meet the clinical requirements of the iliac region.

September 30, 2009 – New clinical data released at TCT 2009 last week showed strong and sustained efficacy and safety of the Resolute Zotarolimus-Eluting Coronary Stent from Medtronic Inc. in long-term patient follow-up.

September 30, 2009 - A new study published in the Society for Vascular Surgery's October 2009 issue of the Journal of Vascular Surgery reports that the elderly have better operative outcomes when endovascular repair, rather than open surgery, is used to treat an abdominal aortic aneurysm (AAA).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now